BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21114789)

  • 1. Switching from brand-name to generic psychotropic medications: a literature review.
    Desmarais JE; Beauclair L; Margolese HC
    CNS Neurosci Ther; 2011 Dec; 17(6):750-60. PubMed ID: 21114789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic equivalence of antipsychotics and antidepressants - A systematic review.
    Cessak G; Rokita K; Dąbrowska M; Sejbuk-Rozbicka K; Zaremba A; Mirowska-Guzel D; Bałkowiec-Iskra E
    Pharmacol Rep; 2016 Apr; 68(2):217-23. PubMed ID: 26922520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational use of generic psychotropic drugs.
    Carbon M; Correll CU
    CNS Drugs; 2013 May; 27(5):353-65. PubMed ID: 23620145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
    Margolese HC; Wolf Y; Desmarais JE; Beauclair L
    Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is a "generic" medication not really a generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
    Kasper S; Lentner S
    Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
    [No Abstract]   [Full Text] [Related]  

  • 9. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.
    Hsu CW; Lee SY; Yang YH; Wang LJ
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):653-661. PubMed ID: 32598470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.
    Emanuele E
    South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do patients learn about psychotropic medications on the web? A natural language processing study.
    Hart KL; Perlis RH; McCoy TH
    J Affect Disord; 2020 Jan; 260():366-371. PubMed ID: 31539672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.
    Smith B; Dubovsky SL
    Expert Opin Pharmacother; 2017 Nov; 18(16):1703-1719. PubMed ID: 29019422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating mood disorders during pregnancy: safety considerations.
    Eberhard-Gran M; Eskild A; Opjordsmoen S
    Drug Saf; 2005; 28(8):695-706. PubMed ID: 16048355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight considerations in psychotropic drug prescribing and switching.
    Hasnain M; Vieweg WV
    Postgrad Med; 2013 Sep; 125(5):117-29. PubMed ID: 24113670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-adherence with psychotropic medications in the general population.
    Bulloch AG; Patten SB
    Soc Psychiatry Psychiatr Epidemiol; 2010 Jan; 45(1):47-56. PubMed ID: 19347238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Psychotropic Medications on Bone Health in Youth.
    Rice JN; Gillett CB; Malas NM
    Curr Psychiatry Rep; 2018 Sep; 20(11):104. PubMed ID: 30246221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatic side effects of psychopharmaceuticals].
    Schmidmeier R
    MMW Fortschr Med; 2006 Nov; 148(46):27-9. PubMed ID: 17615784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.